Literature DB >> 14769914

Rho activity critically and selectively regulates endothelial cell organization during angiogenesis.

Mien V Hoang1, Mary C Whelan, Donald R Senger.   

Abstract

The mechanisms that control organization of endothelial cells (ECs) into new blood vessels are poorly understood. We hypothesized that the GTPase Rho, which regulates cytoskeletal architecture, is important for EC organization during neovascularization. To test this hypothesis, we designed a highly versatile mouse skin model that used vascular endothelial growth factor-expressing cells together with packaging cells producing retroviruses encoding RhoA GTPase mutants. In this animal model, dominant negative N19RhoA selectively impaired assembly of ECs into new blood vessels; and, in contrast, active V14RhoA stimulated ECs to form blood vessels with functional lumens. In vitro, dominant negative N19RhoA reduced EC actin stress fibers and prevented ECs from contracting and reorganizing into precapillary cords within collagen gels. In contrast, active V14RhoA promoted EC stress fiber formation, contractility, and organization into cords. Neither N19RhoA nor V14RhoA significantly affected EC proliferation or migration in vitro; and, similarly, neither mutant significantly affected EC density during angiogenesis in vivo. Thus, these studies identify a critical and selective role for Rho activity in regulating EC assembly into new blood vessels, and they identify both negative and positive manipulation of Rho activity, respectively, as strategies for suppressing or promoting the organizational stages of neovascularization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769914      PMCID: PMC357020          DOI: 10.1073/pnas.0308525100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Clinical applications of angiogenic growth factors and their inhibitors.

Authors:  N Ferrara; K Alitalo
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  The suppression of small GTPase rho signal transduction pathway inhibits angiogenesis in vitro and in vivo.

Authors:  S Uchida; G Watanabe; Y Shimada; M Maeda; A Kawabe; A Mori; S Arii; M Uehata; T Kishimoto; T Oikawa; M Imamura
Journal:  Biochem Biophys Res Commun       Date:  2000-03-16       Impact factor: 3.575

3.  Circulating endothelial precursors: mystery, reality, and promise.

Authors:  S Rafii
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 4.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Authors:  J M Isner; T Asahara
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 5.  Rho family GTPases: more than simple switches.

Authors:  M Symons; J Settleman
Journal:  Trends Cell Biol       Date:  2000-10       Impact factor: 20.808

Review 6.  Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases.

Authors:  L A Feig
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

7.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

8.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

Review 9.  VEGF and vascular fusion: implications for normal and pathological vessels.

Authors:  C J Drake; C D Little
Journal:  J Histochem Cytochem       Date:  1999-11       Impact factor: 2.479

10.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.

Authors:  L E Smith; W Shen; C Perruzzi; S Soker; F Kinose; X Xu; G Robinson; S Driver; J Bischoff; B Zhang; J M Schaeffer; D R Senger
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

View more
  79 in total

1.  Quantification of local matrix deformations and mechanical properties during capillary morphogenesis in 3D.

Authors:  Ekaterina Kniazeva; John W Weidling; Rahul Singh; Elliot L Botvinick; Michelle A Digman; Enrico Gratton; Andrew J Putnam
Journal:  Integr Biol (Camb)       Date:  2012-01-26       Impact factor: 2.192

2.  Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1.

Authors:  Mien V Hoang; Janice A Nagy; Donald R Senger
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation.

Authors:  Gefei Zeng; Sarah M Taylor; Janet R McColm; Nicholas C Kappas; Joseph B Kearney; Lucy H Williams; Mary E Hartnett; Victoria L Bautch
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

4.  Nutritional factors and progenitor cell differentiation.

Authors:  A Dembinska-Kie C; A Polus; J Grzybowska; B Kiec-Wilk; A Balwierz; J Keijer; G Schmitz
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

5.  Automated time-lapse microscopy and high-resolution tracking of cell migration.

Authors:  Joseph S Fotos; Vivek P Patel; Norman J Karin; Murali K Temburni; John T Koh; Deni S Galileo
Journal:  Cytotechnology       Date:  2006-08-08       Impact factor: 2.058

Review 6.  Cellular and molecular mechanisms underlying blood vessel lumen formation.

Authors:  Marta S Charpentier; Frank L Conlon
Journal:  Bioessays       Date:  2013-12-09       Impact factor: 4.345

Review 7.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

8.  Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.

Authors:  Donald R Senger; Mien V Hoang; Ki Hyun Kim; Chunshun Li; Shugeng Cao
Journal:  J Ethnopharmacol       Date:  2016-09-20       Impact factor: 4.360

9.  Fibronectin fibrillogenesis regulates three-dimensional neovessel formation.

Authors:  Xiaoming Zhou; R Grant Rowe; Nobuaki Hiraoka; Jerry P George; Denis Wirtz; Deane F Mosher; Ismo Virtanen; Michael A Chernousov; Stephen J Weiss
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

10.  Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Authors:  Joyce N Gonzales; Kyung-mi Kim; Marina A Zemskova; Ruslan Rafikov; Brenten Heeke; Matthew N Varn; Stephen Black; Thomas P Kennedy; Alexander D Verin; Evgeny A Zemskov
Journal:  Vascul Pharmacol       Date:  2014-01-25       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.